The POU2F3 subtype (SCLC-P), representing 7% of SCLC tumors, is characterized by the absence of expression of ASCL1, NEUROD1, and neuroendocrine markers [28]. The gene discussed is NEUROD1; the disease is small cell lung carcinoma.